Laxmi Bank Supports Tilganga Institute for Diagnosis and Treatment of Eye Cancer Among Children

  1 min 52 sec to read
Laxmi Bank Supports Tilganga Institute for Diagnosis and Treatment of Eye Cancer Among Children

November 10: Laxmi Bank has signed a Memorandum of Understanding (MOU) with Nepal Eye program of Tilganga Institute of Ophthalmology to support diagnosis and treatment of Childhood Eye Cancer, technically known as Retinoblastoma.

Ajaya Bikram Shah, CEO of the bank, and Reeta Gurung, CEO of Tilganga Institute of Ophthalmology, signed the MOU amid a recent function.

The bank said in a statement that it shall provide a fund of Rs 500,000 as an initiative under its Corporate Social Responsibility (CSR) for the diagnosis and treatment of Retinoblastoma patients from deprived financial background.

According to the statement, Retinoblastoma is a rare eye cancer of childhood that arises in the retina.

“It is the most common intraocular malignancy of infancy and childhood; with an incidence of 1 in 15,000 to 1 in 18,000 live births worldwide, mostly occurring to children from birth till 5 years. If the disease is diagnosed and treated on time, chances of saving life, eye and vision is very high,” the statement added.

In Nepal, Tilganga Institute of Ophthalmology has started its treatment, which include chemotherapy, laser therapy, plaque brachy therapy and surgery whenever needed.

The bank said it aims to support the sustainable development goals for good health and well-being by providing financial support to the hospital for diagnosis and treatment of Childhood Eye Cancer.

No comments yet. Be the first one to comment.